202 related articles for article (PubMed ID: 26876532)
1. EZH2 and ZFX oncogenes in malignant behaviour of parathyroid neoplasms.
Sanpaolo E; Miroballo M; Corbetta S; Verdelli C; Baorda F; Balsamo T; Graziano P; Fabrizio FP; Cinque L; Scillitani A; Muscarella LA; Guarnieri V
Endocrine; 2016 Oct; 54(1):55-59. PubMed ID: 26876532
[TBL] [Abstract][Full Text] [Related]
2. Integrated Whole-Exome and Transcriptome Sequencing of Sporadic Parathyroid Adenoma.
Hu Y; Zhang X; Wang O; Cui M; Li X; Wang M; Hua S; Liao Q
Front Endocrinol (Lausanne); 2021; 12():631680. PubMed ID: 34054720
[TBL] [Abstract][Full Text] [Related]
3. The histone methyltransferase EZH2, an oncogene common to benign and malignant parathyroid tumors.
Svedlund J; Barazeghi E; Stålberg P; Hellman P; Åkerström G; Björklund P; Westin G
Endocr Relat Cancer; 2014 Apr; 21(2):231-9. PubMed ID: 24292603
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological correlates of hyperparathyroidism.
Duan K; Gomez Hernandez K; Mete O
J Clin Pathol; 2015 Oct; 68(10):771-87. PubMed ID: 26163537
[TBL] [Abstract][Full Text] [Related]
5. Frequency of somatic MEN1 gene mutations in monoclonal parathyroid tumours of patients with primary hyperparathyroidism.
Miedlich S; Krohn K; Lamesch P; Müller A; Paschke R
Eur J Endocrinol; 2000 Jul; 143(1):47-54. PubMed ID: 10870030
[TBL] [Abstract][Full Text] [Related]
6. Whole-Exome Sequencing Identifies Novel Recurrent Somatic Mutations in Sporadic Parathyroid Adenomas.
Wei Z; Sun B; Wang ZP; He JW; Fu WZ; Fan YB; Zhang ZL
Endocrinology; 2018 Aug; 159(8):3061-3068. PubMed ID: 29982334
[TBL] [Abstract][Full Text] [Related]
7. Identification of somatic mutations in parathyroid tumors using whole-exome sequencing.
Cromer MK; Starker LF; Choi M; Udelsman R; Nelson-Williams C; Lifton RP; Carling T
J Clin Endocrinol Metab; 2012 Sep; 97(9):E1774-81. PubMed ID: 22740705
[TBL] [Abstract][Full Text] [Related]
8. EZH2 copy number and mutational analyses in sporadic parathyroid adenomas.
Romano R; Soong CP; Rose M; Costa-Guda J; Bellizzi J; Arnold A
Endocrine; 2017 Mar; 55(3):985-988. PubMed ID: 27738890
[No Abstract] [Full Text] [Related]
9. Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas.
Pardi E; Marcocci C; Borsari S; Saponaro F; Torregrossa L; Tancredi M; Raspini B; Basolo F; Cetani F
J Clin Endocrinol Metab; 2013 Jul; 98(7):2800-10. PubMed ID: 23633209
[TBL] [Abstract][Full Text] [Related]
10. Familial isolated primary hyperparathyroidism with parathyroid carcinomas: clinical and molecular features.
Yoshimoto K; Endo H; Tsuyuguchi M; Tanaka C; Kimura T; Iwahana H; Kato G; Sano T; Itakura M
Clin Endocrinol (Oxf); 1998 Jan; 48(1):67-72. PubMed ID: 9509070
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity of HRPT2 mutation screening to detect parathyroid carcinoma and atypical parathyroid adenoma of Thai patients.
Niramitmahapanya S; Sunthornthepvarakul T; Deerochanawong C; Sarinnapakorn V; Athipan P; Harnsomboonvana P; Kongsaengdao S
J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S17-22. PubMed ID: 21717873
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylated in cancer 1 (HIC1), a tumor suppressor gene epigenetically deregulated in hyperparathyroid tumors by histone H3 lysine modification.
Svedlund J; Koskinen Edblom S; Marquez VE; Åkerström G; Björklund P; Westin G
J Clin Endocrinol Metab; 2012 Jul; 97(7):E1307-15. PubMed ID: 22544915
[TBL] [Abstract][Full Text] [Related]
13. Aberrant methylation of the HRPT2 gene in parathyroid carcinoma.
Hewitt KM; Sharma PK; Samowitz W; Hobbs M
Ann Otol Rhinol Laryngol; 2007 Dec; 116(12):928-33. PubMed ID: 18217513
[TBL] [Abstract][Full Text] [Related]
14. Surveillance for early detection of aggressive parathyroid disease: carcinoma and atypical adenoma in familial isolated hyperparathyroidism associated with a germline HRPT2 mutation.
Kelly TG; Shattuck TM; Reyes-Mugica M; Stewart AF; Simonds WF; Udelsman R; Arnold A; Carpenter TO
J Bone Miner Res; 2006 Oct; 21(10):1666-71. PubMed ID: 16995822
[TBL] [Abstract][Full Text] [Related]
15. A case of familial isolated hyperparathyroidism with ectopic parathyroid cancer.
Yamashita K; Suzuki S; Yumita W; Ikeo Y; Uehara Y; Minemura K; Sakurai A; Hashizume K
Endocr J; 2001 Aug; 48(4):453-8. PubMed ID: 11603567
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Activating GCM2 Sequence Variants in Sporadic Parathyroid Adenomas.
Riccardi A; Aspir T; Shen L; Kuo CL; Brown TC; Korah R; Murtha TD; Bellizzi J; Parham K; Carling T; Costa-Guda J; Arnold A
J Clin Endocrinol Metab; 2019 Jun; 104(6):1948-1952. PubMed ID: 30624640
[TBL] [Abstract][Full Text] [Related]
17. [The use of flow cytometry in the study of parathyroid hyperplasia and adenomas].
Mangili F; Sassi I; Schiaffino E; Zogno C; Cantaboni A; Schmid C
Pathologica; 1992; 84(1092):459-65. PubMed ID: 1491887
[TBL] [Abstract][Full Text] [Related]
18. Progression of uremic hyperparathyroidism involves allelic loss on chromosome 11.
Falchetti A; Bale AE; Amorosi A; Bordi C; Cicchi P; Bandini S; Marx SJ; Brandi ML
J Clin Endocrinol Metab; 1993 Jan; 76(1):139-44. PubMed ID: 8421078
[TBL] [Abstract][Full Text] [Related]
19. Molecular genetics of hyperparathyroid disease.
Tominaga Y; Takagi H
Curr Opin Nephrol Hypertens; 1996 Jul; 5(4):336-41. PubMed ID: 8823531
[TBL] [Abstract][Full Text] [Related]
20. Studies in a kindred with parathyroid carcinoma.
Streeten EA; Weinstein LS; Norton JA; Mulvihill JJ; White BJ; Friedman E; Jaffe G; Brandi ML; Stewart K; Zimering MB
J Clin Endocrinol Metab; 1992 Aug; 75(2):362-6. PubMed ID: 1639936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]